FrancophonIA/ELRC3.0 huggingface dataset:
English: Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, acute and repeated dose toxicity, local tolerance, fertility, embryo-foetal and postnatal toxicity (up to the end of the lactation period).
Danish: De prækliniske data viser ingen særlig risiko for mennesker vurderet ud fra konventionelle undersøgelser af sikkerhedsfarmakologi, toksicitet efter akut og gentagne doser, lokal tolerance, fertilitet, samt for embryo-/foster- og postnatal-toksicitet (til og med afslutningen af ammeperioden).
English: The efficacy of Cervarix was assessed in two controlled, double-blind, randomised Phase II and III clinical trials that included a total of 19,778 women aged 15 to 25 years.
Danish: Virkningen af Cervarix blev undersøgt i 2 kontrollerede, dobbeltblinde, randomiserede kliniske fase II- og III-studier, som inkluderede i alt 19.778 kvinder i alderen fra 15 til 25 år.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION 1 dose (0.5 ml) contains:
Danish: KVALITATIV OG KVANTITATIV SAMMENSÆTNING 1 dosis (0,5 ml) indeholder:
English: 58, 59, 66 and 68 - Were seronegative for HPV-16 and HPV-18 and - Had normal cytology
Danish: 59, 66 og 68 - var seronegative for HPV-16 og HPV-18 - havde normal cytologi
English: 6M PI in subjects seropositive at baseline only
Danish: 6-måneders PI hos personer kun seropositive ved baseline
English: However, studies conducted in girls aged 9 to 14 years (study HPV-071) and in women aged 18 to 45 years (study HPV-010) have consistently shown a higher immune response with Cervarix than with the comparator for which efficacy data against anal premalignant lesions are conclusive and have shown protection.
Danish: Dog viser studier, udført hos piger i alderen 9 til 14 år (studie HPV-071) og hos kvinder i alderen 18 til 45 år (studie HPV-010), et konsekvent højere immunrespons med Cervarix end med komparator, for hvilken effektdata mod præmaligne anale celleforandringer er konkluderende og har vist beskyttelse.
English: A subset of women (N=776) vaccinated in study 001 was followed in study 007 up to 6.4 years (approximately 77 months) after the first dose (mean follow-up of 5.9 years).
Danish: En undergruppe af kvinder (N = 776) vaccineret i studie 001 blev fulgt i studie 007 i op til 6,4 år (ca. 77 måneder) efter første dosis (middel-opfølgningstid på 5,9 år).
English: Cervarix is not likely to affect your ability to drive or use machines.
Danish: Det er usandsynligt, at Cervarix påvirker evnen til at føre motorkøretøj eller betjene maskiner.
English: • fainting sometimes accompanied by shaking or stiffness.
Danish: • besvimelse, som kan være ledsaget af rysten eller stivhed.
English: Cervarix is a vaccine intended to protect from the age of 9 years against the diseases caused by infection with Human Papillomaviruses (HPV).
Danish: Cervarix er en vaccine, der beskytter fra 9-års alderen mod sygdomme forårsaget af infektion med humant papillomvirus (HPV).
English: Clinical trials Infections and infestations
Danish: Kliniske studier Infektioner og parasitære sygdomme
English: Fainting can occur (mostly in adolescents) following, or even before, any needle injection.
Danish: Besvimelse kan opstå (overvejende hos unge) efter og endda før vaccination med nål.
English: Syncope (fainting) can occur following, or even before, any vaccination especially in adolescents as a psychogenic response to the needle injection.
Danish: Synkope (besvimelse) kan opstå efter og endda før vaccination af især unge mennesker, som en psykogen reaktion over for kanylestik.
English: Bridging of clinical efficacy against anal lesions and cancers
Danish: Sammenkobling af klinisk effekt overfor anale celleforandringer og cancer
English: Vaccination is not a substitute for routine cervical screening.
Danish: Vaccination erstatter ikke regelmæssig cervikal screening.
English: There was no evidence of protection from disease caused by HPV in subjects aged 25 years and above who were DNA positive and/ or with abnormal cytology at study entry.
Danish: Der er ikke evidens for beskyttelse mod sygdom forårsaget af HPV hos personer der er 25 år eller derover, som var DNA positive og/ eller med abnorm cytologi ved inkludering i studiet.
English: The vaccine should under no circumstances be administered intravascularly or intradermally.
Danish: Vaccinen må under ingen omstændigheder gives intravaskulært eller intradermalt.
English: Persistence of Immune Response to Cervarix
Danish: Vedvarende immunrespons over for Cervarix
English: 16 or HPV-18) (2) mean follow-up of 40 months post dose 3
Danish: 16 eller HPV-18) (2) middel-opfølgningstid på 40 måneder efter tredje vaccinedosis
English: The primary endpoint was a combination of a virological and a histopathological endpoint: HPV16/18 related 6-month persistent infection and/or CIN1+.
Danish: Det primære endepunkt var en kombination af et virologisk og et histopatologisk endepunkt: HPV16/18 relateret 6-måneders persisterende infektion og/eller CIN1+.
English: The antibody response to HPV-16 and HPV-18 was measured using a type-specific direct ELISA (version 2, MedImmune methodology, modified by GSK) which was shown to correlate with the pseudovirion-based neutralisation assay (PBNA).
Danish: Antistofrespons mod HPV-16 og HPV-18 blev målt ved hjælp af en type-specifik direkte-ELISA (version 2, MedImmune metodik, modificeret af GSK), som viste korrelation til pseudovirionbaseret neutraliseringsbestemmelse (PBNA).
English: In a supplemental analysis, the efficacy of Cervarix was evaluated against HPV-16/18-related CIN3+.
Danish: I en supplerende analyse blev effekten af Cervarix mod HPV-16/18-relateret CIN3+ evalueret.
English: Women (N=1,113) were vaccinated in study 001 and evaluated for efficacy up to month 27.
Danish: I studie 001 blev kvinder (N = 1.113) vaccineret og effekten undersøgt i op til måned 27.
English: Do not use this vaccine after the expiry date which is stated on the carton.
Danish: Brug ikke denne vaccine efter den udløbsdato, der står på pakningen efter EXP. Udløbsdatoen er den sidste dag i den nævnte måned.
English: What you need to know before you receive Cervarix
Danish: Det skal du vide, før du får Cervarix
English: Efficacy against HPV types 16 and 18 in women with and without prior infection or disease.
Danish: Effekt mod HPV-type 16 og 18 hos kvinder med eller uden eksisterende infektion eller sygdom.
English: Gastrointestinal symptoms including nausea, vomiting, diarrhoea and abdominal pain
Danish: Gastrointestinale symptomer, herunder kvalme, opkastning, diarré og abdominalsmerter
English: Vaccine-induced IgG Geometric Mean Titres (GMT) were well above titres observed in women previously infected but who cleared HPV infection (natural infection).
Danish: Vaccine-induceret IgG GMT var markant højere end titerne observeret hos kvinder, som selv havde bekæmpet en tidligere HPV-infektion (naturlig infektion).
English: Table 7 - Vaccine efficacy at study conclusion in study HPV-015 Endpoint
Danish: Tabel 7: Effekt af vaccinen ved afslutningen af studie HPV-015
English: The cross-protective efficacy of Cervarix against histopathological and virological endpoints (persistent infection) has been evaluated in study HPV-008 for 12 non-vaccine oncogenic HPV types.
Danish: Den krydsbeskyttende effekt af Cervarix mod histopatologiske og virologiske endepunkter (persisterende infektion) er vurderet i studiet HPV-008 for 12 onkogene ikke-vaccine HPV-typer.
English: ♦ Very common (side effects which may occur in more than 1 per 10 doses of vaccine):
Danish: ♦ Meget almindelige (bivirkninger, som kan forekomme ved mere end 1 ud af 10 vaccinationer):
English: METHOD AND ROUTE(S) OF ADMINISTRATION Read the package leaflet before use
Danish: ANVENDELSESMÅDE OG ADMINISTRATIONSVEJ(E) Læs indlægssedlen inden brug.
English: Cervarix should not be given:
Danish: Du må ikke få Cervarix:
English: Control (N = 8,708)
Danish: Kontrol (N = 8.708)
English: The proportion of subjects reaching anti-HBs ≥ 10mIU/ml was 98.3% for concomitant vaccination and 100% for Twinrix given alone.
Danish: Procentdelen af de personer, som opnåede en anti-HB ≥ 10 mIE/ml, var 98,3 % efter samtidig vaccination og 100 % efter administration af Twinrix alene.
English: If you are pregnant, if pregnancy occurs during the course of vaccination or if you are trying to become pregnant it is recommended to postpone or interrupt vaccination until after completion of the pregnancy.
Danish: Hvis du er gravid, hvis du bliver gravid i løbet af vaccinationsprogrammet, eller hvis du planlægger at blive gravid, anbefales det at udskyde vaccinationen, til graviditeten er afsluttet.
English: Administration of Cervarix at the same time as Twinrix has shown no clinically relevant interference in the antibody response to the HPV and hepatitis A antigens.
Danish: Administration af Cervarix samtidigt med Twinrix har vist, at der ikke er nogen klinisk relevant interferens i antistofresponset mod HPV- og hepatitis A-antigen.
English: 470 subjects (142 aged 15-25 years, 172 aged 26-45 years and 156 aged 46-55 years) who completed study HPV-014 and received the 3 dose schedule were followed-up for up to 10 years in the extension study HPV-060.
Danish: 470 personer (142 i alderen 15-25 år, 172 i alderen 26-45 år og 156 i alderen 4655 år) som gennemførte HPV-014 studiet og modtog et 3 dosis vaccinationsprogram, blev fulgt i op til 10 år i forlængelsesstudiet HPV-060.
English: 6.6 Special precautions for disposal and other handling Pre-filled syringe
Danish: 6.6 Regler for bortskaffelse og anden håndtering Fyldt injektionssprøjte
English: The doctor or nurse will give Cervarix as an injection into the muscle of the upper arm. How much is given
Danish: Lægen eller sygeplejersken vil give Cervarix som en injektion i overarmsmusklen.
English: The phase III trial (study 008) enrolled women without pre-screening for the presence of HPV infection, i.e. regardless of baseline cytology and HPV serological and DNA status.
Danish: Fase III-studiet (studie 008) inkluderede kvinder uden forudgående screening for tilstedeværelsen af HPV-infektion, dvs. uden hensyntagen til cytologisk udgangspunkt, HPV-serologi og DNA-status.
English: If Cervarix is to be given at the same time as another injectable vaccine, the vaccines should always be administered at different injection sites.
Danish: Hvis Cervarix administreres samtidigt med andre injicerbare vacciner, skal vaccinerne altid injiceres på forskellige injektionssteder.
English: (NaH2PO4.2 H2O) and water for injections.
Danish: (NaH2PO4, 2 H2O), vand til injektionsvæsker.
English: The primary analyses of efficacy were performed on the ATP cohort for efficacy and the TVC which included a subset of up to 15% of women with a history of HPV-associated infection or disease (defined as two or more abnormal smears in sequence, abnormal colposcopy, or biopsy or treatment of the cervix after abnormal smear or colposcopy findings).
Danish: De primære analyser af effekten blev udført på ATP-kohorten for effekt og på TVC-kohorten, hvilket inkluderede en delgruppe af op til 15 % af kvinderne med en anamnese med HPV-associoseret infektion eller sygdom (defineret som to eller flere på hinanden følgende abnorme celleprøver, abnorm kolposkopi, eller biopsi, eller behandling af livmoderhalsen efter fund af abnorm celleprøve eller kolposkopi).
English: Similar results were observed when Cervarix was given concomitantly with Engerix B with 97.9% of subjects reaching anti-HBs ≥ 10mIU/ml compared to 100% for Engerix B given alone.
Danish: Tilsvarende resultater blev set efter samtidig administration af Cervarix og Engerix-B, hvor 97,9 % af personerne opnåede en anti-HBs ≥ 10 mIE/ml sammenlignet med 100 % efter administration af Engerix-B alene.
English: However, some of the effects mentioned under section 4.8 “Undesirable effects” may temporarily affect the ability to drive or use machines.
Danish: 4.8 ”Bivirkninger”, muligvis påvirke evnen til at føre motorkøretøj eller betjene maskiner.
English: Sodium dihydrogen phosphate dihydrate Water for injections
Danish: Natriumdihydrogenphosphatdihydrat Vand til injektionsvæsker
English: If not used at the end of this period the vaccine should be discarded.
Danish: Hvis vaccinen ikke er anvendt inden for denne periode, skal den kasseres.
English: All initially seropositive women remained seropositive for both anti-HPV-16 and anti-HPV-18 antibodies.
Danish: Alle initielt seropositive kvinder forblev seropositive for både anti-HPV-16 og anti-HPV-18 antistof.
English: In clinical studies that enrolled girls and women aged from 10 up to 72 years (of which 79.2% were aged 10-25 years at the time of enrolment), Cervarix was administered to 16,142 females whilst 13,811 females received control.
Danish: I kliniske studier med piger og kvinder i alderen 10 til 72 år, (hvor 79,2 % var i alderen 10 til 25 år ved inklusion), blev Cervarix administreret til 16.142 piger og kvinder, mens 13.811 fik kontrolvaccine.
English: Vaccine efficacy against the primary endpoint CIN2+at the end of study is presented in Table 1.
Danish: Effekten af vaccinen mod det primære endepunkt CIN2+ ved slutningen af studiet er anført i tabel 1.
English: Warnings and precautions Talk to your doctor or pharmacist before you are given Cervarix
Danish: Kontakt lægen eller apotekspersonalet, før du får Cervarix
English: There was no evidence of protection from disease caused by the HPV types for which subjects were HPV DNA positive at study entry.
Danish: Der var ingen evidens for beskyttelse mod sygdom forårsaget af de HPV-typer, som personerne var HPV-DNA-positive over for ved inkludering i studiet.
English: Cervarix will not protect against other diseases that are not caused by Human Papillomavirus.
Danish: Cervarix beskytter ikke mod sygdomme, som ikke skyldes humant papillomvirus.
English: • swollen glands in the neck, armpit or groin
Danish: • hævede kirtler i hals, armhule eller lyske
English: If you miss a dose
Danish: Hvis du har glemt en vaccination
English: Side effects that occurred during clinical trials with Cervarix were as follows:
Danish: Følgende bivirkninger blev set i kliniske studier med Cervarix:
English: Cervarix is intended for use from 9 years of age onwards.
Danish: Cervarix er beregnet til brug hos personer på 9 år og opefter.
English: 92 subjects in the vaccine group had immunogenicity data at the [M107M113] interval after the first vaccine dose with a median follow-up of 8.9 years.
Danish: Immunogenicitetsdata er vurderet hos 92 personer i vaccinegruppen i tidsintervallet 107-113 måneder (M107-M113) efter første vaccinedosis med en medianopfølgningstid på 8,9 år.
English: Ten years after administration of the first dose, 100% of subjects in the 15-25 years group, 99.2% in the 26-45 years group and 96.3% in the 46-55 years group were still seropositive for HPV-16, and 99.2%, 93.7% and 83.8% for HPV-18, respectively.
Danish: Ti år efter administration af den første dosis var 100 % af personerne i gruppen 15-25 år, 99,2 % i gruppen 26-45 år og 96,3 % i gruppen 46-55 år stadig seropositive overfor HPV-16, og henholdsvis 99,2 %, 93,7 % og 83,3 % overfor HPV-18.
English: In study HPV-023, subjects from the Brazilian cohort (N=437) of study 001/007 were followed up to a mean of 8.9 years (standard deviation 0.4 years) after the first dose.
Danish: I studie HPV-023 blev personer fra den brasilianske kohorte (N = 437) fra studie 001/007 fulgt i gennemsnitligt op til 8,9 år efter første dosis (standardafvigelse 0,4 år).
English: There were sixteen cases of persistent HPV-16 infection, and five cases of persistent HPV-18 infection, all in the control group.
Danish: Der var 16 tilfælde af persisterende HPV-16-infektioner og 5 tilfælde af persisterende HPV-18-infektioner, alle i kontrolgruppen.
English: At the 84-month time point, i.e. 78 months after completion of the full vaccination course, 99.3% and 95.9% of initially seronegative women remained seropositive for anti-HPV-16 and anti-HPV-18 antibodies, respectively.
Danish: Ved måned 84, dvs. 78 måneder efter afslutningen af det fulde vaccinationsprogram, forblev henholdsvis 99,3 % og 95,9 % af de initielt seronegative kvinder seropositive for anti-HPV-16- og anti-HPV-18-antistof.
English: At end of study analysis, there were 2 cases of VIN2+ or VaIN2+ in the vaccine group and 7 cases in the control group in the ATP cohort associated with HPV-16 or HPV-18.
Danish: I analysen ved afslutningen af studiet var der 2 tilfælde af VIN2+ eller VaIN2+ i vaccinegruppen og 7 tilfælde i kontrolgruppen i ATP-kohorten associeret med HPV-16 eller HPV-18.
English: In clinical trials, more than 99% of initially seronegative subjects had seroconverted to both HPV types 16 and 18 one month after the third dose.
Danish: I kliniske studier havde mere end 99 % af initialt seronegative personer serokonverteret for både HPVtype 16 og 18 en måned efter 3. dosis.
English: 3adsorbed on aluminium hydroxide, hydrated (Al(OH)3)
Danish: 3adsorberet på aluminiumhydroxidhydrat (Al(OH)3)
English: Evidence of Anamnestic (Immune Memory) Response
Danish: Evidens for anamnestisk respons (immunhukommelsesrespons)
English: To attach the needle to the syringe, twist the needle clockwise into the syringe until you feel it lock.
Danish: Kanylen sættes på injektionssprøjten ved at skrue kanylen med uret, indtil man har en fornemmelse af, at den låser.
English: Cervarix will only protect against diseases that are caused by HPV types 16 and 18 and to some extent against diseases caused by certain other oncogenic related HPV types (see section 5.1).
Danish: Cervarix beskytter kun mod sygdom, som er forårsaget af HPV-type 16 og 18, samt til en vis grad mod sygdom forårsaget af visse relaterede onkogene HPV-typer (se pkt.
English: Cervarix is an adjuvanted non-infectious recombinant vaccine prepared from the highly purified viruslike particles (VLPs) of the major capsid L1 protein of oncogenic HPV types 16 and 18.
Danish: Cervarix er en adjuveret, ikke-infektiøs rekombinant vaccine fremstillet i en højtoprenset viruslignende partikel (VLP) af kapsidproteinet L1 fra de onkogene HPV-typer 16 og 18.
English: Of these subjects, 100% (95% CI: 96.1;100) remained seropositive for HPV-16 and HPV-18 in the ELISA assay.
Danish: 100 % (95 % CI: 96,1; 100) forblev seropositive over for HPV-16 og HPV18 målt ved ELISA.
English: Cervarix is for intramuscular injection in the deltoid region (see also sections 4.4 and 4.5).
Danish: Cervarix skal injiceres intramuskulært i regio deltoidea (se også pkt.
English: HPV type assignment analysis (see under Table).
Danish: Disse tilfælde er ekskluderet i analysen for HPV-type-bestemmelse (se under tabel).
English: EU/1/07/419/008 - pack of 1 without needle EU/1/07/419/009 - pack of 10 without needle EU/1/07/419/004 - pack of 1 with 1 needle EU/1/07/419/006 - pack of 10 with 10 needles EU/1/07/419/005 - pack of 1 with 2 needles EU/1/07/419/007 - pack of 10 with 20 needles
Danish: EU/1/07/419/008 - pakningsstørrelse på 1 uden kanyle EU/1/07/419/009 - pakningsstørrelse på 10 uden kanyler EU/1/07/419/004 - pakningsstørrelse på 1 med 1 kanyle EU/1/07/419/006 - pakningsstørrelse på 10 med 10 kanyler EU/1/07/419/005 - pakningsstørrelse på 1 med 2 kanyler EU/1/07/419/007 - pakningsstørrelse på 10 med 20 kanyler
English: Cervarix is a vaccine for use from the age of 9 years for the prevention of premalignant ano-genital lesions (cervical, vulvar, vaginal and anal) and cervical and anal cancers causally related to certain oncogenic Human Papillomavirus (HPV) types.
Danish: Cervarix er en vaccine til brug hos personer på 9 år og derover til forebyggelse af præmaligne anogenitale celleforandringer (cervikale, vulvale, vaginale og anale) og cervix- og analcancer, der er kausalt relateret til visse onkogene typer af humant papillomvirus (HPV).
English: Sodium dihydrogen phosphate dihydrate (NaH2PO4.2 H2O) Water for injections
Danish: Natriumdihydrogenphosphatdihydrat (NaH2PO4, 2 H2O) Vand til injektionsvæsker
English: Post-marketing experience Blood and lymphatic system disorders
Danish: Erfaring efter markedsføring Blod og lymfesystem Ikke kendt*
English: In the event of either being observed, discard the vaccine.
Danish: Ved observation af et af de ovennævnte forhold skal vaccinen kasseres.
English: Side effects that have been reported during marketed use of Cervarix include:
Danish: Følgende bivirkninger er set efter markedsføringen af Cervarix:
English: Two analyses of study HPV-008 have been performed: an event-triggered analysis performed once at least 36 CIN2+ cases associated with HPV-16/18 were accrued in the ATP cohort and an end-of study analysis.
Danish: To analyser af studiet HPV-008 er udført: En hændelsesudløst analyse, der blev udført én gang, da mindst 36 CIN2+ tilfælde associeret med HPV-16/18 var identificeret i ATP-kohorten, samt en analyse ved slutningen af studiet (end-of-study analyse).
English: The term “premalignant ano-genital lesions” in section 4.1 corresponds to high-grade Cervical Intraepithelial Neoplasia (CIN2/3), high-grade vulvar intraepithelial neoplasia (VIN2/3), high-grade vaginal intraepithelial neoplasia (VaIN2/3) and high-grade anal intraepithelial neoplasia (AIN 2/3).
Danish: 4.1, refererer til high-grade cervikal intraepitelial neoplasi (CIN2/3), high-grade vulval intraepitelial neoplasi (VIN 2/3), highgrade vaginal intraepitelial neoplasi (VaIN 2/3) og high-grade anal intraepitelial neoplasi (AIN 2/3).
English: Cervarix does not protect people from diseases caused by infection with HPV types 16 or 18 if they are already infected with Human Papillomavirus type 16 or 18 at the time of vaccination.
Danish: Cervarix beskytter ikke mod sygdom forårsaget af HPV-type 16 eller 18, hvis du på vaccinationstidspunktet allerede har en infektion med HPV-type 16 eller 18.
English: In the Phase III study (HPV-015) in women 26 years and older all subjects seroconverted one month after the third dose.
Danish: I et fase III-studie (HPV-015) med kvinder i alderen 26 år og derover, serokonverterede alle personerne en måned efter den tredje dosis.
English: In two clinical studies that enrolled males aged 10 to 18 years, 2,617 males received Cervarix and were followed-up with active safety surveillance.
Danish: I to kliniske studier med drenge og unge mænd i alderen 10 til 18 år blev Cervarix administreret til 2.617 mandlige personer, som blev fulgt med aktiv overvågning af sikkerheden.
English: Case counting for the TVC started on day 1 after the first dose.
Danish: Registreringen af tilfælde i TVC-kohorten startede på dag 1 efter første vaccinedosis.
English: Pack sizes of 1, 10 and 100 vials.
Danish: Pakningsstørrelser på 1, 10 og 100 hætteglas.
English: How Cervarix is given
Danish: Sådan gives Cervarix
English: In study 007 the efficacy of Cervarix against 12-month persistent HPV-16/18 infection was 100% (95% CI: 80.5; 100).
Danish: I studie 007 var effekten af Cervarix mod 12-måneders persisterende HPV16/18-infektion 100 % (95 % CI: 80,5;100).
English: It is recommended that subjects who receive a first dose of Cervarix complete the vaccination course with Cervarix (see section 4.4).
Danish: Det anbefales, at personer, som har fået Cervarix som første dosis, gennemfører hele vaccinationsprogrammet med Cervarix (se pkt.
English: Holding the syringe barrel in one hand (avoid holding the syringe plunger), unscrew the syringe cap by twisting it anticlockwise.
Danish: Hold injektionssprøjten i den ene hånd (undgå at holde på injektionsstemplet) og skru beskyttelseshætten af ved at dreje den mod uret.
English: HPV-16/18 endpoint
Danish: HPV-16/18 endepunkt
English: STATEMENT OF ACTIVE SUBSTANCE(S) 1 dose (0.5 ml) contains:
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER 1 dosis (0,5 ml) indeholder:
English: If Cervarix is to be given at the same time as another injectable vaccine, the vaccines should always be administered at different injection sites (see section 4.5).
Danish: Hvis Cervarix skal gives samtidig med andre injicerbare vacciner, skal vaccinerne altid administreres på forskellige injektionssteder (se pkt.
English: Prophylactic efficacy against HPV-16/18 infection in a population naïve to oncogenic HPV types
Danish: Forebyggende effekt mod HPV-16/18-infektion i en population, som var naive over for onkogene HPV-typer